CONVERSALL Trademark

Trademark Overview


On Thursday, August 26, 2021, a trademark application was filed for CONVERSALL with the United States Patent and Trademark Office. The USPTO has given the CONVERSALL trademark a serial number of 90904032. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 17, 2023. This trademark is owned by Vivera Pharmaceuticals Inc.. The CONVERSALL trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; Medicinal preparations for mental health disorders; Medicinal preparations for stuttering; Medicinal preparations for diabetes; Dietary supplements; Drug delivery agents in the form of sublingual tablets that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of sublingual capsules that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of sublingual gel strips that facilitate the delivery of pharmaceutical preparations; Medical preparations for t...
conversall

General Information


Serial Number90904032
Word MarkCONVERSALL
Filing DateThursday, August 26, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 19, 2022

Trademark Statements


Description of MarkThe mark consists of the wording "CONVERSALL" in blue below a design comprised of a stylized word balloon in light blue and red that contains a stylized brain in blue that appears on the left of three dots that form an ellipsis in blue.
Goods and ServicesDrug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; Medicinal preparations for mental health disorders; Medicinal preparations for stuttering; Medicinal preparations for diabetes; Dietary supplements; Drug delivery agents in the form of sublingual tablets that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of sublingual capsules that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of sublingual gel strips that facilitate the delivery of pharmaceutical preparations; Medical preparations for the treatment of mental health disorders; Medical preparations for the treatment of stuttering; Medical preparations for the treatment of diabetes; Nutritional supplements; Pharmaceutical preparations for mental health disorders; Pharmaceutical preparations for stuttering; Pharmaceutical preparations for diabetes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Sexual stimulant preparations in the form of sublingual tablets containing sildenafil citrate; Sexual stimulant preparations in the form of sublingual capsules containing sildenafil citrate; Sexual stimulant preparations in the form of sublingual gel strips containing sildenafil citrate
Indication of Colors claimedThe color(s) blue and red is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVivera Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660

Party NameVivera Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660

Trademark Events


Event DateEvent Description
Thursday, March 7, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 7, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 7, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 7, 2024WITHDRAWAL OF ATTORNEY GRANTED
Thursday, March 7, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Monday, April 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 17, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 29, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 9, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 8, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 8, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 22, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 22, 2021NON-FINAL ACTION E-MAILED
Wednesday, December 22, 2021NON-FINAL ACTION WRITTEN
Tuesday, December 21, 2021ASSIGNED TO EXAMINER
Wednesday, October 13, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, October 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 30, 2021NEW APPLICATION ENTERED